
Why Injective? Canary Capital CEO @StevenMcClurg answers on @therollupco. Top 10 revenue generating chain even while outside the top 20 by market cap. Real use cases paying real fees onchain. That's the signal institutions are watching as the $INJ ETF filing gains traction.



















